West, Anthony P. Jr. http://orcid.org/0000-0003-4213-5184
Wertheim, Joel O.
Wang, Jade C. http://orcid.org/0000-0002-8855-0925
Vasylyeva, Tetyana I.
Havens, Jennifer L.
Chowdhury, Moinuddin A.
Gonzalez, Edimarlyn
Fang, Courtney E.
Di Lonardo, Steve S.
Hughes, Scott
Rakeman, Jennifer L.
Lee, Henry H.
Barnes, Christopher O.
Gnanapragasam, Priyanthi N. P.
Yang, Zhi
Gaebler, Christian
Caskey, Marina
Nussenzweig, Michel C. http://orcid.org/0000-0003-0592-8564
Keeffe, Jennifer R. http://orcid.org/0000-0002-5317-6398
Bjorkman, Pamela J. http://orcid.org/0000-0002-2277-3990
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-002143)
Caltech Merkin Institute for Translational Research
Article History
Received: 10 June 2021
Accepted: 28 July 2021
First Online: 9 August 2021
Competing interests
: P.J.B. is a co-inventor on a provisional application from the California Institute of Technology for the use of mosaic nanoparticles as coronavirus immunogens. M.C.N., P.J.B. and C.O.B. are co-inventors on provisional applications for several anti-SARS-CoV-2 monoclonal antibodies. J.O.W. has received funding from Gilead Sciences, LLC (completed) and the CDC (ongoing) via grants and contracts to his institution unrelated to this research. All other authors declare no competing interests.